发明名称 Cardiovascular monitoring for fluid removal processes
摘要 A method includes initiating a blood fluid removal session for a patient in need thereof; monitoring a cardiovascular parameter of the patient; determining whether the indicator of the cardiovascular state crosses a predetermined threshold; and altering a parameter of the blood fluid removal session if the indicator is determined have crossed the threshold.
申请公布号 US9061099(B2) 申请公布日期 2015.06.23
申请号 US201213424490 申请日期 2012.03.20
申请人 Medtronic, Inc. 发明人 Gerber Martin;Burnes John;Lyu Suping;VenKatesh Manda R.;Pudil Bryant
分类号 A61M37/00;C02F1/44;A61M1/16;A61B5/00;A61B5/026;A61B5/053;A61B5/145;A61M1/34;B01D65/02;A61M1/00;A61B5/0295;A61M1/14;B01D61/00;B01D61/32;A61M1/36 主分类号 A61M37/00
代理机构 Hahn & Voight PLLC 代理人 Hahn & Voight PLLC ;Hahn Roger C.;Collier Kenneth J.
主权项 1. A method carried out by a blood fluid removal device or system, comprising: initiating a blood fluid removal session for a patient in need thereof; monitoring a cardiovascular parameter and at least one additional physiological parameter of the patient with at least one sensor; determining whether an indicator of the cardiovascular parameter or physiological parameter crosses a predetermined threshold; and altering a parameter of the blood fluid removal session if the indicator is determined to have crossed the threshold, wherein the blood fluid removal device comprises control electronics, wherein the control electronics are configured to control one or more flow control elements to adjust a pH or electrolyte concentration of a replacement fluid based on the data from the at least one sensor; and wherein altering a parameter of the blood fluid removal session comprises setting or adjusting the pH and electrolyte concentration of the replacement fluid based at least on the cardiovascular or physiological parameter of the patient wherein the step of altering the parameter of the blood fluid removal session is carried out by the blood fluid removal device.
地址 Minneapolis MN US